Historical record - last NADAC publication: 9/18/2019
Product Information
RALOXIFENE HCL 60 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.5340 per EA under NDC 68462039301. Its NADAC has been published 169 times since Jul 13, 2016.
The High Outlier badge above means this manufacturer's average price in the raloxifene hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462039301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
9/18/2019
Active Ingredients
RALOXIFENE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204491On Market Since
3/22/2016
Pharmacological Classes
Price Statistics
The NADAC for RALOXIFENE HCL 60 MG TABLET has been published 169 times since Jul 13, 2016, and over the history we have for it it has declined 77.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5340 per EA |
|---|---|
| All-time high | $2.3853 (Jul 13, 2016) |
| All-time low | $0.5252 (Apr 17, 2019) |
| Median price | $0.8596 |
| Average price | $1.0313 |
| Largest weekly change | -20.1% (Apr 18, 2018) |
| Weeks tracked | 169 |
| Tracking since | Jul 13, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RALOXIFENE HCL 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RALOXIFENE HCL 60 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.5340 per EA (NDC 68462039301), effective Oct 2, 2019.
How has the price of RALOXIFENE HCL 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for RALOXIFENE HCL 60 MG TABLET has declined 77.6%. It has been tracked across 169 weekly CMS publications since Jul 13, 2016.
What are the highest and lowest recorded NADAC prices for RALOXIFENE HCL 60 MG TABLET?
Since Jul 13, 2016, the NADAC for RALOXIFENE HCL 60 MG TABLET has ranged from a low of $0.5252 (Apr 17, 2019) to a high of $2.3853 (Jul 13, 2016), with a median of $0.8596 per EA.
Are there cheaper alternatives to RALOXIFENE HCL 60 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as RALOXIFENE HCL 60 MG TABLET, but none are currently priced below it.
Who manufactures RALOXIFENE HCL 60 MG TABLET?
RALOXIFENE HCL 60 MG TABLET (NDC 68462039301) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification